On October 8, BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS fell 5.1% in regular trading to $344.835 per share, with turnover of $27.7672 million. The primary catalyst behind the move was the consecutive reduction of holdings by founding shareholder Wang Xiaodong, which dampened short-term market sentiment.

According to regulatory filings, Wang Xiaodong, a Director and Chairman of the Scientific Advisory Board, completed two concentrated batches of ADS sales in September, realizing over $24.68 million in combined proceeds. The most recent disposal occurred on September 28, involving the exercise and immediate sale of 31,000 ADS at a weighted average price of approximately $364.79 per share, amounting to about $11.32 million.

While the company's interim results were strong, with first-half net profit surging 385.8% year-on-year to $464 million driven by robust sales of its flagship product Brukinsa, and it has recently drawn capital inflows in the Hong Kong biopharmaceutical sector, the high-profile insider selling is regarded as the direct event affecting this particular share-price movement.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)